The IASLC 19th World Conference on Lung Cancer Arrives in Toronto, Canada
DENVER, Aug. 21, 2018 (GLOBE NEWSWIRE) --
What: The International Association for the Study of Lung Cancer (IASLC) presents the IASLC 19th World Conference on Lung Cancer (WCLC) on September 23-26, 2018, in Toronto, Canada. The WCLC is the world’s largest meeting dedicated solely to lung cancer and other thoracic malignancies, and is expected to convene over 7,000 researchers, physicians, specialists, patients, advocates and industry members from around the world.
The WCLC’s scientific program features a line-up of global leaders in the field. Presentations focus on cutting-edge science, including the latest breakthroughs in targeted therapies and immunotherapies; advances in screening, early detection and staging; prevention and smoking cessation efforts; patient advocacy initiatives; and much more. Collaboration across disciplines and borders is a meeting highlight. The WCLC’s scientific program is available to review online.
When and Where: September 23-26, 2018, Metro Toronto Convention Centre North Building, 255 Front Street West, Toronto, Ontario, M5V 2W6, Canada
Who: Surgeons, medical oncologists, radiation oncologists, pulmonologists, radiologists, pathologists, epidemiologists, basic research scientists, nurses, allied health professionals, advocates, industry representatives and media partners will gather to share findings and to further progress.
More information: Visit the conference’s official website for more information or to register.
About the WCLC:
The World Conference on Lung Cancer (WCLC) is the world’s largest meeting dedicated solely to lung cancer and other thoracic malignancies, attracting over 7,000 researchers, physicians and specialists from more than 100 countries. The conference will cover a wide range of disciplines and unveil research studies and clinical trial results. For more information, visit http://wclc2018.iaslc.org/. Follow the conference on social media with: #WCLC2018.
About the IASLC:
The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 7,500 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information. You can also follow the IASLC on Twitter, Facebook, LinkedIn and Instagram.
Contact: Becky Bunn, MSc
IASLC Public Relations Manager
Becky.Bunn@iaslc.org | 720-325-2946
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/5f8c0583-657a-48a2-9d8b-0b3bd7897a6c
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Press Release on the Filing of a Draft Offer Document Relating to the Simplified Tender Offer For the shares of Believe initiated by Upbeat BidCo SAS26.4.2024 15:20:00 CEST | Press release
PRICE OF THE OFFER: €15 per Believe share DURATION OF THE OFFER: 15 trading days The timetable of the tender offer (the “Offer”) will be set out by the Autorité des marchés financiers (the “AMF”) in accordance with the provisions of its General Regulation. This press release (the “Press Release”) was prepared by Upbeat BidCo and published pursuant to Article 231-16 of the General Regulation of the AMF. The offer and the draft offer document remain subject to review by the AMF. IMPORTANT NOTICE The Press Release must be read together with all other documents published in connection with the Offer. In particular, in accordance with Article 231-28 of the General Regulation of the AMF, a description of the legal, financial and accounting characteristics of Upbeat BidCo will be filed with the AMF and made available to the public no later than the day preceding the opening of the Offer. A press release will be issued to inform the public of the manner in which this information will be made a
The arbitral tribunal has confirmed GF’s redemption right over the minority shares in Uponor and trading in Uponor’s shares has been suspended26.4.2024 15:15:00 CEST | Press release
Uponor Corporation, Stock Exchange Release, April 26, 2024, 4.15 p.m. EET The arbitral tribunal has confirmed GF’s redemption right over the minority shares in Uponor and trading in Uponor’s shares has been suspended The arbitral tribunal appointed by the Redemption Committee of the Finland Chamber of Commerce in connection with the redemption proceedings concerning the minority shares in Uponor Corporation (“Uponor”) has in its interim award confirmed that Georg Fischer AG (“GF”) has the right to redeem the minority shares in Uponor and that GF has the right to obtain title to the minority shares by posting a security approved by the arbitral tribunal for the payment of the redemption price and the possible interest accruing thereon. Uponor announced on March 22, 2024, that Uponor has resolved to apply for the termination of public trading in its shares and for the delisting of its shares from the Official List of Nasdaq Helsinki Ltd (“Nasdaq Helsinki”) so that the delisting would occ
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)26.4.2024 15:00:00 CEST | Press release
ORION CORPORATION STOCK EXCHANGE RELEASE – MAJOR SHAREHOLDER ANNOUNCEMENTS 26 APRIL 2024 at 16.00 EEST Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion Corporation has received a disclosure under Chapter 9, Section 5 of the Securities Market Act, according to which the total number of Orion shares owned directly, indirectly and through financial instruments by BlackRock, Inc. and its funds decreased on 25 April 2024 below five (5) per cent of Orion Corporation’s total shares. Total positions of BlackRock, Inc. and its funds subject to notification: % of shares and voting rights (total of point A)% of shares and voting rights through financial instruments (total of point B)Total of both in % (points A + B)Total number of shares and voting rights of issuer Resulting situation on the date on which threshold was crossed or reached Below 5% shares Below 5% voting rights Below 5% shares Below 5% voting rights Below 5% shares Below
Decisions of the Organisational Meeting of Harvia Plc’s Board of Directors26.4.2024 15:00:00 CEST | Press release
STOCK EXCHANGE RELEASE 26 April 2024, at 4.00 p.m. EEST Decisions of the Organisational Meeting of Harvia Plc’s Board of Directors Heiner Olbrich was elected the Chair and Catharina Stackelberg-Hammarén was elected the Vice Chair of the Board of Directors at the Board of Directors’ organisational meeting that took place today after Harvia Plc’s Annual General Meeting. Board of Directors elected from among its members Hille Korhonen (Chair), Anders Holmén and Markus Lengauer as members of the Audit Committee. In addition, Harvia Plc’s Board of Directors decided to establish a Personnel and Remuneration Committee. The Committee’s task is to assist the Board of Directors in issues related to personnel and remuneration. The Board of Directors elected from among its members Heiner Olbrich (Chair), Olli Liitola and Catharina Stackelberg-Hammarén as members of the Personnel and Remuneration Committee. Independence of the members of the Board of Directors The Board of Directors assessed the in
Ålandsbanken Abp: Transaktioner utförda av personer i ledande ställning (Eurell)26.4.2024 15:00:00 CEST | Pressemelding
Ålandsbanken Abp Transaktioner utförda av personer i ledande ställning 26.4.2024 kl.16.00 EET Transaktioner utförda av personer i ledande ställning Den anmälningsskyldiga Namn: Jan-Gunnar Eurell Befattning: Ekonomidirektör Emittent: Ålandsbanken Abp LEI: 7437006WYM821IJ3MN73 Anmälans karaktär: FÖRSTA ANMÄLAN Referensnummer: 60063/8/4 Transaktionens datum: 2024-04-26 Handelsplats: NASDAQ HELSINKI LTD (XHEL) Instrument typ: AKTIE ISIN: FI0009001127 Transaktionens karaktär: FÖRVÄRV Detaljer om transaktionerna (1): Volym: 265 Enhetspris: 34.1611 EUR Aggregerad information om transaktionerna (1): Volym: 265 Medelpris: 34.1611 EUR Ytterligare information: Peter Wiklöf, Vd och koncernchef, Ålandsbanken Abp, tfn +358 40 512 7505